Form: 3

Initial statement of beneficial ownership of securities

October 29, 2024

POA

Published on October 29, 2024

POWER OF ATTORNEY

Known all by these presents, that the undersigned hereby
constitutes and appoints each of Lorna A. Knick and Clay O. Martin,
and each of them acting alone, signing singly, the undersigned's
true and lawful attorney-in-fact to: (1) execute for and on behalf of the
undersigned, in the undersigned's capacity as an officer, director and/or
10% or more stockholder of Ocuphire Pharma, Inc. (to be renamed "Opus
Genetics Inc.") (the "Company"),Forms ID, 3, 4, 5, and Update
Passphrase Acknowledgement (and any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended
(the "1934 Act") and Schedules 13D and/or Schedules 13G (and any
amendments thereto) in accordance with the 1934 Act, and the rules
promulgated thereunder; (2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or desirable to
complete and execute any such Form ID, 3, 4, 5, and Update Passphrase
Acknowledgement and Schedules 13D and/or Schedules 13G (and
any amendments thereto) and to file timely such form with the
United States Securities and Exchange Commission and any stock
exchange or similar authority; and (3) take any other action of any type
whatsoever in connection with the foregoing which in the opinion of such
attorney-in-fact may be of benefit to, in the best interest of, or
legally required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such
form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-
fact full power and authority to do and perform any and every
act and thing whatsoever requisite, necessary or proper to be
done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and
confirming that all such attorneys-in-fact, or such attorneys-
in-facts' substitute or substitutes, shall lawfully do or
cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the 1934 Act.

The undersigned attests and agrees that the use of an electronic
signature in any authentication document that includes the
undersigned signatory's typed, conformed signature, and that is
filed with or furnished to the Securities and Exchange Commission
by or on behalf of the undersigned signatory, the Company or any
of its affiliates, constitutes the legal equivalent of the
undersigned signatory's manual signature for purposes of
authenticating the undersigned signatory's signature to any filing
or submission for which it is provided.

This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms
ID, 3, 4 and 5 and Schedules 13D and Schedules 13G with respect to the
undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 23rd day of October 2024.

FOUNDATION FIGHTING BLINDNESS, INC.

By: /s/ Jason Menzo
Jason Menzo, Chief Executive Officer